Skip to main content
$37.49 -$1.74 (-4.4%)

04:00 PM EDT on 05/12/21

Pain Therapeutics Inc (NASDAQ:SAVA)

CAPS Rating: 1 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Current Price $37.49 Mkt Cap $1.6B
Open $39.14 P/E Ratio 0.00
Prev. Close $39.23 Div. (Yield) $0.00 (0.0%)
Daily Range $37.36 - $39.90 Volume 825,729
52-Wk Range $1.63 - $117.54 Avg. Daily Vol. 1,725,302

Caps

How do you think NASDAQ:SAVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

183 Outperform
30 Underperform
 

All-Star Players

32 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SAVA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Simbalion200 (< 20)
Submitted April 09, 2010

Pain Therapeutics, Inc. is a biopharmaceutical company that develops drugs. As of December 31, 2009, the Company had four drug candidates in clinical programs, including REMOXY, PTI-202, PTI-721 and a radio-labeled monoclonal antibody to treat… More

SmartAce (99.84)
Submitted August 27, 2018

My 5 year old son just asked “what if we put a slice of turkey in the DVD player and it played a movie about the turkey’s whole life” and none of the parenting books I’ve read have prepared me for this question.

Recent Community Commentary

Read the most recent pitches from players about SAVA.

Recs

0
Member Avatar naughtyguy (34.43) Submitted: 3/20/2021 3:39:38 PM : Underperform Start Price: $57.03 NASDAQ:SAVA Score: +38.20

This is WAY overbought!

Recs

0
Member Avatar TMFacarchidi (< 20) Submitted: 3/4/2021 2:29:05 PM : Outperform Start Price: $44.03 NASDAQ:SAVA Score: -22.86

Highly promising Alzheimer's therapy that's about to enter phase 3 clinical trials.

Recs

0
Member Avatar mdriver78 (73.90) Submitted: 2/18/2021 12:57:37 PM : Outperform Start Price: $50.34 NASDAQ:SAVA Score: -29.74

Buy Alzheimer break through in Phase II Trials

Leaderboard

Find the members with the highest scoring picks in SAVA.

Score Leader

medeaschild

medeaschild (69.04) Score: +4,756.55

The Score Leader is the player with the highest score across all their picks in SAVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
medeaschild 69.04 12/26/2018 Outperform NS $0.76 +4,828.36% +71.81% +4,756.55 0 Comment
SmallCapSurfer2 93.12 10/13/2016 Outperform 3M $5.32 +604.70% +91.09% +513.61 0 Comment
foolrrrrrrrrrr 48.60 11/13/2008 Underperform 1Y $37.61 -0.31% +392.19% +392.50 0 Comment
capptten < 20 12/1/2020 Outperform 3M $7.66 +389.43% +10.90% +378.53 1 Comment
marcet 74.38 3/2/2009 Underperform 3W $18.82 +99.16% +468.94% +369.79 0 Comment
Dennyf10 60.29 10/16/2008 6/22/2009 Underperform 1Y $35.72 +4.94% +354.36% +349.42 0 Comment
hackerbobZ < 20 3/23/2009 Underperform 5Y $17.65 +112.38% +420.25% +307.87 0 Comment
deemonfather42 < 20 7/6/2009 Underperform 3W $22.42 +67.20% +355.51% +288.30 0 Comment
jornoski 54.33 9/21/2020 Outperform 5Y $9.45 +296.72% +24.47% +272.25 0 Comment
OklaBoston 63.08 9/21/2020 Outperform 3Y $9.45 +296.72% +24.47% +272.25 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SAVA.